Prevalence and factors associated with the generalized anxiety disorder among people living with HIV/AIDS in Brazilian outpatient clinics

Introduction: The Generalized Anxiety Disorder (GAD) is a chronic worrying disorder, which causes social and occupational impairment. Objective: The aim of this study was to estimate the prevalence of GAD among people living with HIV/AIDS (PLWHA) and to determine the associated socio-demographic and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista de medicina da Universidade Federal do Ceará 2019-09, Vol.59 (3), p.32-38
Hauptverfasser: Santana, Rafael Dantas, Pinho, Carolina Saraiva Nunes, Pinheiro Junior, Francisco Marto Leal, Bezerra, Fabrício Maicy, Cavalcante, Malena Gadelha, Campos, Eugênio de Moura, Pires Neto, Roberto da Justa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: The Generalized Anxiety Disorder (GAD) is a chronic worrying disorder, which causes social and occupational impairment. Objective: The aim of this study was to estimate the prevalence of GAD among people living with HIV/AIDS (PLWHA) and to determine the associated socio-demographic and clinical factors. Methodology: We conducted a cross-sectional study between September 2014 and April 2015 at four HIV outpatient clinics in Fortaleza, Northeastern Brazil. We surveyed 257 individuals living with HIV/AIDS, aged > 18-years, of both sexes. Four modalities of instruments were used to collect the data: a socio-demographic questionnaire; the Mini International Neuropsychiatric Interview; the Hamilton’s Anxiety Scale; and chart data. Results: GAD prevalence was 14%. Female sex, CD4 200-500 versus < 200, CD4 > 500 versus < 200 and being homeless were associated in the multivariate model. Conclusion: The study demonstrates the necessity of proactively addressing mental health as well as physical health issues in HIV+ individuals.
ISSN:0100-1302
2447-6595
DOI:10.20513/2447-6595.2019v59n3p32-38